Market Overview
For the Quarter Ending December 2025
Bismuth Subsalicylate Prices in APAC
In China, the Bismuth Subsalicylate Price Index rose by 6.36% QoQ, driven by pharmaceutical demand firming.
The average Bismuth Subsalicylate price for the quarter was approximately USD 29780.00/MT, reflecting Q4 stability overall.
Bismuth Subsalicylate Spot Price firmed as exporters held offers while Shanghai inventories tightened amid winter maintenance.
Bismuth Subsalicylate Price Forecast suggests modest monthly gains driven by steady hospital tenders and export inquiries.
Bismuth Subsalicylate Production Cost Trend rose with firmer refined bismuth metal quotations increasing formulators' input expenses.
Bismuth Subsalicylate Demand Outlook remains constructive as OTC growth and export contract volumes support ongoing procurement.
Bismuth Subsalicylate Price Index registered measured upward bias while inventories shortened and buying remained disciplined overall.
Winter inspections and maintenance trimmed refined availability modestly, yet rail and port logistics avoided significant disruptions.
Why did the price of Bismuth Subsalicylate change in December 2025 in APAC?
Supply disruptions and maintenance reduced immediate availability, tightening spot markets and supporting marginal upward price pressure locally.
Firmer refined bismuth metal quotations increased production costs, influencing formulators' offers and sustaining FOB Shanghai pricing margins.
Hospital tender deliveries and export contract shipments maintained steady offtake, preventing notable destocking and stabilizing market fundamentals.
Bismuth Subsalicylate Prices in North America
In the USA, the Bismuth Subsalicylate Price Index rose modestly quarter-over-quarter, reflecting firm pharmaceutical demand from OTC and hospital segments.
The average Bismuth Subsalicylate price for the quarter remained stable, supported by limited domestic supply and continued procurement by pharmaceutical formulators.
Bismuth Subsalicylate Spot Price strengthened in Q4 as inventories at key distribution centers tightened, while producers maintained disciplined offers.
Bismuth Subsalicylate Production Cost Trend increased due to higher refined bismuth metal costs, influencing formulation and pricing strategies.
Bismuth Subsalicylate Demand Outlook remains robust, underpinned by steady OTC sales, hospital tenders, and some export contract volumes.
In September 2025, the Price Index increased owing to tighter refined bismuth availability and restocking by pharmaceutical distributors ahead of seasonal demand.
Bismuth Subsalicylate Price Forecast anticipates moderate upward pressure in the near term, supported by stable downstream procurement and ongoing cost pressures.
Price Index movements were influenced by inventory drawdowns, selective spot purchases, and continuous hospital and OTC demand, keeping the market moderately firm.
Bismuth Subsalicylate Prices in Europe
In Germany, France, and Italy, the Bismuth Subsalicylate Price Index rose quarter-over-quarter, supported by pharmaceutical and OTC demand for gastrointestinal formulations.
Average prices remained firm as spot availability tightened, reflecting production and logistics constraints.
Bismuth Subsalicylate Spot Price strengthened as distributors competed for limited cargoes, while integrated producers maintained steady operating rates.
Bismuth Subsalicylate Production Cost Trend saw modest increases, largely due to higher refined bismuth metal quotations impacting formulation costs.
Bismuth Subsalicylate Demand Outlook stayed constructive, driven by seasonal uptick in OTC gastrointestinal products and ongoing hospital contracts.
In September 2025, the Price Index increased as European buyers replenished inventories post-summer and refined bismuth supply tightened.
Bismuth Subsalicylate Price Forecast suggests stable to slightly bullish trends in the short term, depending on feedstock pricing and export allocation.
Price Index volatility remained limited due to steady logistics, disciplined producer offers, and measured downstream restocking, preventing sharp price swings.
For the Quarter Ending September 2025 North America
In United States, the Bismuth Subsalicylate Price Index rose quarter-over-quarter in Q3 2025, driven by robust demand and rising production costs.
Production costs increased due to a 2.6% year-over-year PPI rise in August 2025, impacting raw materials and operational expenses.
Demand outlook remained strong, supported by a 5.42% retail sales increase and low 4.3% unemployment in September 2025.
Consumer-level inflation, indicated by a 3.0% CPI increase year-over-year in September 2025, raised overall operational expenses.
The pharmaceutical sector experienced notably increased FDA drug approvals in Q3 2025, boosting demand for active ingredients.
Chemical inventories in the US shrank in Q3 2025, with raw materials inventory levels contracting due to destocking efforts.
US chemical production activity appeared to contract in Q3 2025, with more firms reporting declining output levels.
Why did the price of Bismuth Subsalicylate change in September 2025 in North America?
Rising production costs were driven by a 2.6% year-over-year PPI increase in August 2025.
Strong consumer spending, evidenced by a 5.42% retail sales increase in September 2025, boosted demand.
Shrinking chemical inventories in Q3 2025, coupled with contracting US chemical production, tightened supply.
APAC
In China, the Bismuth Subsalicylate Price Index rose quarter-over-quarter in Q3 2025.
Production costs for Bismuth Subsalicylate rose in Q3 2025 due to moderate upward pressure on salicylic acid feedstock in the quarter.
Demand for Bismuth Subsalicylate was sustained by China's thriving pharmaceutical market and aging population.
Retail sales increased 3.0% year-over-year in September 2025, yet consumer confidence remained low (89.6 index).
Industrial production expanded 6.5% year-over-year in September 2025, indirectly supporting economic stability.
Persistent oversupply in global chemical markets, including China, pressured Bismuth Subsalicylate prices downward.
Chinese salicylic acid manufacturers tightened operating rates in Q3 2025 due to environmental inspections, curtailing supply.
Why did the price of Bismuth Subsalicylate change in September 2025 in APAC?
Declining PPI (-2.3% YoY in September 2025) reduced input costs for Bismuth Subsalicylate production.
Persistent oversupply in China's chemical markets during Q3 2025 exerted downward pressure on prices.
Upward pressure on salicylic acid feedstock costs and energy tariffs increased production expenses.
Europe
In Germany, Bismuth Subsalicylate Price Index rose in Q3 2025, due to surging raw material costs and tightened inventories.
Production costs faced upward pressure in Q3 2025, despite a 1.7% PPI decrease in September.
Demand for Bismuth Subsalicylate showed sustained growth in Q3 2025, supported by increased pharmaceutical manufacturing output.
The Bismuth Subsalicylate price forecast indicates a firm trend, influenced by supply constraints and stable pharmaceutical demand.
Germany's Manufacturing Index was contracting in Q3 2025; industrial production declined 1.0% in September.
European natural gas prices moderated in Q3 2025, yet bismuth raw material costs surged due to export restrictions.
Global bismuth inventories tightened significantly in Q3 2025, while German exports contracted.
Consumer Price Index rose 2.4% in September 2025, impacting purchasing power; retail sales increased 0.2%.
Why did the price of Bismuth Subsalicylate change in September 2025 in Europe?
Bismuth raw material costs surged in Q3 2025, driven by export restrictions and supply constraints.
Global bismuth inventories tightened significantly in Q3 2025, following major stockpile depletion.
Sustained German pharmaceutical demand, with retail sales up 0.2% in September 2025, supported prices.
view historical insights
How We Can Help
ChemAnalyst: Your Source for Real-Time Market News, Weekly Price Updates
Stay ahead of the competition with ChemAnalyst, the premier provider of
actionable market news. We offer real-time updates on prices, tracking and
reporting pricing trends, market news, and demand & supply for over 450
commodities.
Why choose ChemAnalyst? We go beyond just providing prices - we give you the
insights behind them. Our expert analysts not only deliver accurate price
data but also explain the exact reasons why prices have gone up or down.
This knowledge helps you make informed decisions and understand market
dynamics.
Planning your purchase at the right timing is crucial, and that's why we
provide price forecasts. Our forecasts help you anticipate market movements,
enabling you to optimize your procurement strategy and maximize cost
savings. Additionally, we track plant shutdowns to assess any risks
associated with supply disruptions. By keeping you informed about potential
disruptions, we empower you to proactively manage your supply chain and
mitigate any potential issues.
Our Analysts team comprises chemical engineers and experts with strong
backgrounds in economics, manufacturing, supply chain, and trading. With
offices in Houston, Cologne, and New Delhi, we provide a comprehensive view
of the global market. Our ground teams are based out of more than 50+ major
trading ports such as Houston, Shanghai, Busan, Rotterdam, Jebel Ali,
Antwerp, Hamburg, and more. This ensures that we have firsthand information
and insights on market activities, allowing us to deliver accurate and
timely reports.
Don't miss out on valuable insights! Keep your procurement teams informed and
empowered with ChemAnalyst's unparalleled expertise.
Subscribe ChemAnalyst today for the latest market news and stay on top of
your game.
Product Description
Bismuth Subsalicylate is an active pharmaceutical ingredient belonging to the bismuth-based inorganic compound class, primarily recognized for its gastrointestinal therapeutic properties. It is typically produced through the controlled reaction of bismuth salts with salicylic acid under regulated pH and temperature conditions, resulting in a fine, white to pinkish powder with a stable crystalline structure. The compound combines the beneficial attributes of bismuth—known for its antimicrobial and protective coating effects—with the anti-inflammatory characteristics of salicylate chemistry.
The material exhibits several key physicochemical properties, including low solubility in water, mild antimicrobial action, and excellent stability under standard storage conditions. Its ability to form a protective barrier along the gastrointestinal lining, coupled with its capacity to neutralize irritants and reduce inflammation, makes it a valuable ingredient in digestive health formulations. Additionally, Bismuth Subsalicylate demonstrates efficacy against certain gastrointestinal pathogens, contributing to its widespread use in symptomatic relief products.
Bismuth Subsalicylate is extensively applied in the pharmaceutical and consumer healthcare sectors, particularly in over-the-counter medicines designed to treat diarrhea, indigestion, heartburn, nausea, and general stomach discomfort. It is also incorporated into combination therapies for managing Helicobacter pylori infections when paired with antibiotics. Beyond human health applications, the compound is used in veterinary medicine to address digestive disturbances in animals. Its multifunctional therapeutic profile and consistent performance across formulations support its continued relevance in global gastrointestinal care markets.
